A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells.
Genetically engineered T lymphocytes are a promising option for cancer therapy. Prior to adoptive transfer they have to be expanded in vitro to reach therapeutically sufficient numbers. So far, no universal method exists for selective in vitro expansion of engineered T lymphocytes. In order to overc...
Guardado en:
Autores principales: | Marc Cartellieri, Stefanie Koristka, Claudia Arndt, Anja Feldmann, Slava Stamova, Malte von Bonin, Katrin Töpfer, Thomas Krüger, Mathias Geib, Irene Michalk, Achim Temme, Martin Bornhäuser, Dirk Lindemann, Gerhard Ehninger, Michael P Bachmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f142152a744f4caf9d7376f363460801 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Engraftment of donor mesenchymal stem cells in chimeric BXSB includes vascular endothelial cells and hepatocytes
por: Jones OY, et al.
Publicado: (2011) -
Improvement of antibody functionality by structure-guided paratope engraftment
por: Qingbo Liu, et al.
Publicado: (2019) -
Reprogramming mouse fibroblasts into engraftable myeloerythroid and lymphoid progenitors
por: Hui Cheng, et al.
Publicado: (2016) -
Insights from engraftable immunodeficient mouse models of hyperinsulinaemia
por: Michelle L. Maugham, et al.
Publicado: (2017) - Chimerism